Press Room


April 19th, 2012 CHEMAPHOR RECEIVES FIRST U.S. ORDER FOR OXIMUNOL™ CHEWABLES OTTAWA, ONTARIO, April 19, 2012 – Avivagen Animal Health Inc., the commercial arm of Chemaphor Inc.
April 18th, 2012 CHEMAPHOR RELEASES BUSINESS OVERVIEW VIDEO
April 18th, 2012 CHEMAPHOR PURSUING PARTNERING INITIATIVE TO COMMERCIALIZE NON-ANTIBIOTIC FEED ADDITIVE ALTERNATIVE TO IMPROVE PRODUCTIVITY AND SAFETY IN FOOD-PRODUCING ANIMALS OTTAWA, ONTARIO, April 17, 2012 – In light of the quickening pace of regulatory actions in the US relating to the concern about antimicrobial re
March 29th, 2012 Status update on non-antibiotic OxC-beta feed additive OTTAWA, ONTARIO, March 29, 2012 – In light of a recent U.S. court ruling that may lead to a ban of the common agricultural use in the U.S.
March 28th, 2012 Avivagen presents canine supplement at PEI Home Show For Immediate Release
March 20th, 2012 Chemaphor Receives First Approvals for International Feed Additive Patent Application OTTAWA, ONTARIO, March 20, 2012 - Chemaphor Inc.
February 23rd, 2012 AVIVAGEN PASSES NATIONAL ANIMAL SUPPLEMENT COUNCIL CERTIFICATION AUDIT FOR IMMEDIATE RELEASE
February 16th, 2012 Avivagen announces U.S. distribution agreement OTTAWA, ONTARIO, February 15, 2012 – Teva Animal Health, Inc. (TAH) and Avivagen Animal Health, Inc. (AV), a&
February 10th, 2012 CHEMAPHOR PROVIDES CORPORATE UPDATE OTTAWA, ONTARIO, February 10, 2012 – Chemaphor Inc.
December 6th, 2011 Avivagen Exhibits at Winter Woofstock 2011 OTTAWA, ONTARIO, December 6, 2011 – Avivagen Animal Health Inc., a wholly‐owned subsidiary of Chemaphor Inc.